Novo Nordisk fell nearly 2%. Eli Lilly said Zepbound's weight loss effect is much better than Wegovy

2025-05-12 21:58:41

Novo Nordisk fell nearly 2% to $64.5. On the news front, Eli Lilly announced that its weight loss drug Zepbound performed better than Novo Nordisk Wegovy in five weight loss goals in a comparative trial.

weight loss drug Novo Nordisk Lilly

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Hong Kong stocks opened: Hang Seng Index opened 0.14% higher, Hang Seng Technology Index opened 0.13% higher
                            2025-06-06

                                    A U.S. appeals court rejected Apple's (AAPL.O) request to suspend an order on App Store reforms in its lawsuit against Epic Games, court documents showed.
                            2025-06-05

                                    Cainiao continues to deploy logistics + AI and joins hands with China Eastern Airlines to build the world's first smart hangar
                            2025-06-06

                                    South Korea's exports fell 1.3% in May from a year earlier
                            2025-06-01

                                    Project establishment and formulation of safety requirements for combined driving assistance systems for intelligent connected vehicles
                            2025-06-04